Physician profile
David Greco
NPI 1740285204
$34,148.40
in general payments reported to CMS, 2019-2025
30 companies · $14.27 in 2025
The $14.27 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33K · 2020: $1,320 · 2025: $14.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $19,768.40 | 2019-2020 | |
| Genzyme Corporation | $8,009.70 | 2019-2020 | |
| Genentech USA, INC. | $5,137.13 | 2019 | |
| Novartis Pharmaceuticals Corporation | $163.91 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $123.35 | 2019-2020 | |
| Allergan, INC. | $121.07 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $116.41 | 2019 | |
| Acadia Pharmaceuticals INC | $105.99 | 2019-2020 | |
| Boston Scientific Corporation | $92.38 | 2020 | |
| Amgen INC. | $55.00 | 2019 | |
| Sunovion Pharmaceuticals INC. | $51.66 | 2019 | |
| Ge Healthcare | $51.23 | 2020 | |
| Eisai INC. | $49.07 | 2019 | |
| Emd Serono, INC. | $36.41 | 2019 | |
| Avanir Pharmaceuticals, INC. | $30.46 | 2019 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $24.12 | 2019 | |
| Alnylam Pharmaceuticals INC. | $22.97 | 2019 | |
| Lilly USA, LLC | $21.77 | 2019 | |
| Csl Behring | $19.94 | 2019 | |
| Ucb, INC. | $19.57 | 2019 | |
| Sk Life Science, INC. | $18.48 | 2020 | |
| Portola Pharmaceuticals, LLC | $18.06 | 2019 | |
| Amneal Pharmaceuticals LLC | $17.57 | 2020 | |
| Jazz Pharmaceuticals INC. | $16.50 | 2019 | |
| Adlon Therapeutics L.P. | $15.66 | 2019 | |
| Lundbeck LLC | $15.24 | 2019 | |
| Medtronic, INC. | $14.27 | 2025 | Linq II |
| Abbvie INC. | $12.08 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Greco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.